L T Tan1. 1. Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. litee.tan@addenbrookes.nhs.uk
Abstract
AIMS: Image-guided brachytherapy (IGBT) is the new gold standard for cervix cancer brachytherapy. In 2009, the Royal College of Radiologists (RCR) published a guidance document to facilitate the implementation of IGBT for cervix cancer in the UK. This paper reports the progress since the publication of the RCR document. MATERIALS AND METHODS: Questionnaires were sent to 45 UK centres known to offer brachytherapy for cervix cancer in 2011. Replies were received from 43 (96%) centres. Details collected included brachytherapy machine, imaging technique for brachytherapy planning, applicator design and total dose to point A from external beam radiotherapy and brachytherapy. The results were compared with the 2008 survey reported in the RCR document. RESULTS: The number of centres offering computed tomography (CT) or magnetic resonance imaging (MRI)-based IGBT for cervix cancer has increased to 32 (71%) in 2011 compared with 12 (26%) in 2008. Although the most common applicator design in 2011 remains the tandem-ovoid applicator (71%), more respondents are using the tandem-ring applicator (29% versus 9% in 2008). Only seven (16%) centres are routinely prescribing < 70Gy(10) to point A in 2011 compared with 10 (22%) in 2008. CONCLUSION: Considerable progress with implementing IGBT for cervix cancer has been made in the UK since the publication of the RCR guidance document. Copyright Â
AIMS: Image-guided brachytherapy (IGBT) is the new gold standard for cervix cancer brachytherapy. In 2009, the Royal College of Radiologists (RCR) published a guidance document to facilitate the implementation of IGBT for cervix cancer in the UK. This paper reports the progress since the publication of the RCR document. MATERIALS AND METHODS: Questionnaires were sent to 45 UK centres known to offer brachytherapy for cervix cancer in 2011. Replies were received from 43 (96%) centres. Details collected included brachytherapy machine, imaging technique for brachytherapy planning, applicator design and total dose to point A from external beam radiotherapy and brachytherapy. The results were compared with the 2008 survey reported in the RCR document. RESULTS: The number of centres offering computed tomography (CT) or magnetic resonance imaging (MRI)-based IGBT for cervix cancer has increased to 32 (71%) in 2011 compared with 12 (26%) in 2008. Although the most common applicator design in 2011 remains the tandem-ovoid applicator (71%), more respondents are using the tandem-ring applicator (29% versus 9% in 2008). Only seven (16%) centres are routinely prescribing < 70Gy(10) to point A in 2011 compared with 10 (22%) in 2008. CONCLUSION: Considerable progress with implementing IGBT for cervix cancer has been made in the UK since the publication of the RCR guidance document. Copyright Â
Authors: Cameron W Swanick; Katherine O Castle; Sastry Vedam; Mark F Munsell; Lehendrick M Turner; Gaiane M Rauch; Anuja Jhingran; Patricia J Eifel; Ann H Klopp Journal: Int J Radiat Oncol Biol Phys Date: 2016-07-30 Impact factor: 7.038
Authors: Karem R Domínguez Hernández; Alberto A Aguilar Lasserre; Rubén Posada Gómez; José A Palet Guzmán; Blanca E González Sánchez Journal: Comput Math Methods Med Date: 2013-04-18 Impact factor: 2.238